Neurolief Announces Breakthrough Results from Pivotal Clinical Trial of Brain Neuromodulation System for Treating Major Depressive Disorder

This study marks a historic milestone as the first ever Randomized Controlled Trial (RCT) to demonstrate success in a non-pharmacological home therapy for Treatment Resistant Major Depression.

TAMPA, Fla., June 25, 2024 /PRNewswire/ — Neurolief, a leading developer of innovative brain…